Drug Profile
Pseudohypericin
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Lichtwer Pharma
- Class Antidepressants; Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpesvirus infections; HIV infections; Major depressive disorder
Most Recent Events
- 13 Feb 2001 No-Development-Reported for Depression in Germany (Unknown route)
- 07 Feb 2001 No-Development-Reported for Herpesvirus infections in Germany (Unknown route)
- 07 Feb 2001 No-Development-Reported for HIV infections treatment in Germany (Unknown route)